Local and Slow Release of IL4-10 Synerkine as a Disease Modifying Therapy for Osteoarthritis

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2016.01.975
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Short Link N Acts as a Disease Modifying Osteoarthritis Drug

2019English

Discoidin Domain Receptor 2 as a Potential Therapeutic Target for Development of Disease-Modifying Osteoarthritis Drugs

American Journal of Pathology
Forensic MedicinePathology
2016English

The Quest for the Holy Grail: A Disease-Modifying Osteoarthritis Drug

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2007English

Discovery of a Small Molecule Inhibitor of the WNT Pathway (SM04690) as a Potential Disease Modifying Treatment for Knee Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

Multiple Sclerosis Disease-Modifying Therapy and Pregnancy

Multiple Sclerosis
Neurology
2016English

Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Nanoparticle System for the Local Delivery of Disease Modifying Osteoarthritic Drugs

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2013English

Teriparatide as a Chondroregenerative Therapy for Injury-Induced Osteoarthritis

Science Translational Medicine
Medicine
2011English

Phosphate Release From Slow Release Fertilizer Using a Mixture of Chitosan and Potato Flour as a Coating

Jurnal Bahan Alam Terbarukan
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy